ClinicalTrials.govpublic full text
Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
rectal cancer, lymph-node-sparing short-course radiotherapy, capecitabine, pd-1 inhibitor, ctla-4 inhibitor, organ preservation, clinical complete response, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837736
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.